Skip to main content

CompoZr(R) ZFA Targeting Human KLF4

Catalog No.
C15-1355-509
Manufacturer No.
CZFA1504-1KT
Manufacturer Name
Sigma-Aldrich
Quantity
1
Unit of Measure
KT
Price: $2,950.55
List Price: $3,278.39

Zinc finger nucleases (ZFNs) are a class of engineered DNA-binding proteins that facilitate targeted gene editing. Now, Sigma-Aldrich provides ZF activators, repressors and epigenetic modifiers for gene expression studies.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account.

Adding to cart… The item has been added

General description

Zinc finger nucleases (ZFNs) are a class of engineered DNA-binding proteins that facilitate targeted gene editing. Now, Sigma-Aldrich provides ZF activators, repressors and epigenetic modifiers for gene expression studies. ZFAs, or similarly called ZF−TFs (zinc finger transcription factors) incorporate a transcriptional activation domain in place of the nuclease domain found in ZFNs and specifically activate coding and non-coding genes. The increase in specific gene expression is dependent on the target binding site and the effector domain selected. Native gene activation is through ZFAs binding to promoters and recruiting the transcriptional machinery. This approach for activation also has the benefit of expressing endogenous isoforms at the proper ratio.
*Please note all ZFA plasmids are made standard with the p65 activation domain. The end-user will have to swap out the p65 domain and clone in the other activation, epigenetic or repressor domains as needed.

Features and Benefits

CompoZr ZFAs allows researchers to over-express endogenous genes with the advantage of having all splice variants in the appropriate ratios.

  • Validated ZFAs targeting KLF4 (human).
  • ZFA is a powerful, novel tool to modulate gene expression in human cells with low potential for off-targets.

Components

  • Validated ZFA plasmids with the p65 activation domain to upregulate human KLF4.

Preparation Note

Transcription Factor p65, or the RelA NF-kappaB (nuclear factor kappaB) subunit, contains a C-terminal transcriptional activation domain. Additional activation domains are included in the kit, which include plasmids with the 2xp65, VP16 and VP64 activation domains. 2xp65 consists of two repeating units of the p65 activation domain. VP16 is a trans-acting domain from the herpes simplex virus that induces early gene transcription. VP64 is a transactivating domain made up of a tetrameric repeat of VP16 minimal activation domain.

Other Notes

If you are interested in the CompoZr ZFN technology for permanent editing of your gene of interest, please inquire about our Custom ZFN Service offering at: ZFNOps@sial.com

Legal Information

CompoZr is a registered trademark of Sigma-Aldrich Co. LLC

UPC:
51292602
Condition:
New
Weight:
1.00 Ounces
HazmatClass:
No
WeightUOM:
LB
MPN:
CZFA1504-1KT


Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.


"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."

LAB DIRECTOR


"We utilized Cenmed's capabilities for a variety of projects around the world. They are a valued partner and supplier."

PHARMACEUTICAL SUPPLY CHAIN LEADER


"The reps are very good at finding products for customers in this period of supply chain issues."

SCOTT BEHMAN


"Your customer service has been excellent and makes me excited about purchasing with Cenmed in the future!!"

PROCUREMENT + BILLING COORDINATOR AT PHARMA.